相关实验视频

Updated: Jan 16, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

一种常见的PD-风险GBA1变异破坏LIMP2相互作用,损害葡萄糖大脑酶功能,并驱动 lysosomal和线粒体功能障碍

Oliver B Davis¹, Jennifer E Kung¹, Sonnet S Davis¹

¹Denali Therapeutics Inc., South San Francisco, CA, United States.

bioRxiv : the preprint server for biology

|October 1, 2025

概括

与帕金森病相关的GBA1-E326K变体损害了GCase酶到 lysosomes的传递,导致细胞功能障碍. 这一发现为GBA1-PD机制和潜在的治疗点提供了洞察力.

科学领域:

遗传学和分子生物学
神经科学是一个神经科学.
生物化学生物化学

背景情况:

GBA1变种是帕金森病 (PD) 的主要遗传风险因素.
虽然Gaucher病 (GD) 相关的GBA1变体导致功能丧失,但PD特异变体如E326K对GCase活性和PD通路的影响尚不清楚.
了解GCase功能障碍机制对于开发有针对性的PD疗法至关重要.

研究的目的:

为了研究与PD相关的GBA1-E326K变异对GCase活性和 lysosomal功能的功能影响.
阐明由E326K变种引起的GCase功能障碍背后的分子机制.
探索E326K变异对PD相关细胞通路和潜在治疗策略的影响.

主要方法:

对GBA1-E326K变体的生物物理和结构特征及其与LIMP2.2的相互作用.
使用GBA1-p.E326K变异的细胞模型来评估GCase递送,溶解体功能和线粒体活性.
从变异载体中获得的iPSC衍生的微质和生物流体中分析GCase通路活性.

主要成果:

由于LIMP2相互作用的改变,E326K变体通过损害其 lysosomal传递显著降低了 lysosomal GCase活性.
结构分析显示,E326K变体通过破坏关键的盐桥来促进二维的GCase组织.
与严重功能丧失变体相比,GBA1-p.E326K细胞模型在PD相关途径中表现出更大的缺陷,包括脂质储存和线粒体功能障碍.
在中枢神经系统细胞和载体生物流体中证实了E326K变异对GCase活性的影响.

结论:

与PD相关的GBA1-E326K变体通过破坏溶酶体运输和改变蛋白质组织,损害了GCase功能.
这种变异加剧了与帕金森病相关的细胞缺陷,突出显示了它在帕金森病发病过程中的特殊作用.
这些发现为GBA1-PD机制提供了关键的见解,并支持开发针对帕金森病的GCase向疗法.

更多相关视频

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

Published on: December 14, 2017

相关概念视频

Lysosomal Hydrolases

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...